Add like
Add dislike
Add to saved papers

Elective induction of labour may improve outcomes and reduce labour-related complications

2 Minute Medicine 2023 June 15

1. Elective induction of labour at 39 weeks gestation compared to expectant management was associated with reduced likelihood of 3rd and 4th degree perineal injury, operative vaginal birth, macrosomia, and low APGAR score at 5 minutes.

2. For multiparous women, elective induction was associated with a reduced likelihood of emergency Cesarean section.

3. For nulliparous women, elective induction was associated with an increased likelihood of shoulder dystocia.

Evidence Rating Level: 2 (Good)

Study Rundown: Elective induction of labour refers to induction without a medical indication. Such indications could be maternal or neonatal, including 41 weeks gestation, pre-eclampsia, prelabour rupture of membranes, or poor fetal growth. Although elective induction of labour is associated with higher rates of C-section and adverse outcomes compared to spontaneous labour, the ARRIVE Trial found lower C-section rates and improved neonatal outcomes when comparing elective induction at 39 weeks to expectant management, meaning that labour is induced only when medically indicated. Therefore, this systematic review and meta-analysis aimed to compare neonatal outcomes and complications from labour, between 39-week elective induction and expectant management. The study also aimed to include populations who have previously been excluded from such studies, including women with high BMI and patients attempting vaginal birth after a prior C-section. This review screened observational studies and randomized controlled trials; however, most of the studies ultimately included were retrospective cohorts. Overall, the review found that compared to expectant management, 39-week elective induction was associated with reduced odds of 3rd or 4th degree perineal injury, macrosomia, operative vaginal birth, and low APGAR score at 5 minutes. For multiparous women, there was also a reduced odds of C-section. For nulliparous women, there was an increased odds of shoulder dystocia. Overall, this review generally demonstrated reduced likelihood of labour-related complications and poor neonatal outcomes with 39-week elective induction of labour compared to expectant management.

Click here to read the study in JAMA Network Open

Relevant Reading: Labour induction versus expectant management in low-risk nulliparous women

In-Depth [systematic review and meta-anlaysis]: This review ultimately analyzed 14 eligible studies, including 1 randomized controlled trial, 1 cross-sectional study, and 12 retrospective cohort studies. Altogether, these studies included 1,625,899 women with a singleton pregnancy, 86,555 of underwent induction at 39 weeks. The results showed that compared to expectant management, patients had 37% lower odds of 3rd or 4th degree perineal injury (OR 0.63, 95% CI 0.49-0.81), 13% lower odds of operative vaginal birth (OR 0.87, 95% CI 0.79-0.97), 34% lower odds of macrosomia (OR 0.66, 95% CI 0.48-0.91), and 38% lower odds of low 5-minute APGAR score (OR 0.62, 95% CI 0.40-0.96). For nulliparous women, there were also reductions for postpartum hemorrhage (OR 0.89, 95% CI 0.77-1.02) and emergency C-section (OR 0.75, 95% CI 0.53-1.07) that were nonsignificant. For multiparous women, there was also a 39% lower odds of emergency C-section (OR 0.61, 95% CI 0.38-0.98). And finally, for nulliparous women, there was an increased odds of shoulder dystocia (OR 1.22, 95% CI 1.02-1.46). Overall, this review generally demonstrated reduced likelihood of labour-related complications and poor neonatal outcomes with 39-week elective induction of labour compared to expectant management.

Originally Published By 2 Minute Medicine®. Reused on Read by QxMD with permission.

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Add to Saved Papers

Get 1-tap access

Urinary Tract Infections: Core Curriculum 2024.American Journal of Kidney Diseases 2023 October 31

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app